Y. Miyasaka et al., Mild mitral regurgitation was associated with increased prevalence of thromboembolic events in patients with nonrheumatic atrial fibrillation, INT J CARD, 72(3), 2000, pp. 229-233
Citations number
16
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Although several studies demonstrated that the presence of significant mitr
al regurgitation was associated with reduced occurrence of thromboembolism,
little data is available concerning the effect of mild mitral regurgitatio
n on the occurrence of thromboembolic events. To evaluate the association b
etween mild mitral regurgitation and thromboembolic events, we reviewed 232
patients' records between January 1996 and September 1997 who had nonrheum
atic atrial fibrillation. There were 59 patients (25%) with mitral regurgit
ation greater than or equal to grade 2, 69 patients (30%) with grade 1 mitr
al regurgitation, and 104 patients (45%) with no mitral regurgitation. Pati
ents with grade 1 mitral regurgitation had significantly higher prevalence
of thromboembolic events (28%) than those with mitral regurgitation greater
than or equal to grade 2 (8%, P=0.006) or those with no mitral regurgitati
on (11%, P=0.007). A history of previous thromboembolic events were compare
d between 173 patients with grade 1 mitral regurgitation and those with no
mitral regurgitation using the logistic regression analysis adjusted for ag
e, sex, administration of warfarin, and presence of hypertension, diabetes
mellitus, structural heart disease, enlarged left atrium (greater than or e
qual to 40 mm), chronic atrial fibrillation, and grade 1 mitral regurgitati
on. Grade 1 mitral regurgitation (odds ratio=2.689, 95% confidence interval
=1.039-7.189, P=0.0434) and no warfarin administration (odds ratio=0.045, 9
5% confidence interval=0.002-0.242, P=0.0036) were significantly associated
with the history of thromboembolic events, The presence of mild mitral reg
urgitation in nonrheumatic atrial fibrillation was associated with higher p
revalence of thromboembolic events. (C) 2000 Elsevier Science Ireland Ltd.
All rights reserved.